Skip to main content

Table 4 Started postoperative chemotherapy stage II-III

From: A population-based cohort study on adherence to practice guidelines for adjuvant chemotherapy in colorectal cancer

  Stage II Stage III  
  Low risk (%) High risk (%) N1 (%) N2 (%)
Colon cancer 107 539 1425 1088
Capecitabine/5-FU 51 (47.7) 296 (54.9) 662 (46.4) 336 (30.9)
Capecitabine/5-FU+ 42 (39.2) 209 (38.8) 693 (48.6) 689(63.3)
Oxaliplatin     
Other combinations 14 (13.1) 34 (6.3) 70 (4.9) 63 (5.8)
Rectal cancer 135 258 556 471
Capecitabine/5-FU 72 (53.3) 142 (55.0) 294 (52.9) 168 (35.7)
Capecitabine/5-FU+ 33 (24.4) 66 (25.6) 203 (36.5) 245 (52.0)
Oxaliplatin     
Other combinations 28 (20.7) 50 (19.4) 59 (10.6) 58 (12.3)
  1. Abbreviation: 5-FU, 5-fluorouracil.